Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 4Lymphoid 3Gynecologic 3Other solid neoplasm 2Head & Neck 2Breast 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Genitourinary 1CNS 1

Conditions

Pseudomyxoma Peritonei 1Mesothelioma, Malignant 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Appendiceal Neoplasms 1Advanced Cancer 1

Interventions

Cisplatin 81Gemcitabine 58Carboplatin 57Irinotecan 56Paclitaxel 53Pemetrexed 47Docetaxel 39Nivolumab 33Fluorouracil 30Bevacizumab 27pembrolizumab 25Cyclophosphamide 24Capecitabine 24Oxaliplatin 22Leucovorin 21Topotecan 19durvalumab 17Erlotinib Hydrochloride 17Sorafenib 16Everolimus 16Etoposide 16Bortezomib 16Ipilimumab 15Injections 15Sunitinib 14Filgrastim 14Early Intervention, Educational 14atezolizumab 13alvocidib 13Sirolimus 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Referral and Consultation × Other solid neoplasm × Clear all
NCT03181854 2019-08-06

Randomized Controlled Trial of Integrated Early Palliative Care

Seoul National University Hospital

Phase NA Completed
144 enrolled
Other solid neoplasm

Advanced Cancer

NCT01126346 2018-07-03

HOPE

Wake Forest University Health Sciences

Phase NA Completed
10 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Appendiceal Neoplasms, Colonic Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡